Companies › WRBY

WRBY 10-K & 10-Q changes, risk factors and insider trading

Warby Parker Inc. · NYSE · Ophthalmic Goods · CIK 1504776 · All filings on SEC.gov

Everything below is quoted or computed from Warby Parker Inc.'s public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

17 / 65risk-factor paragraphs added / removed in latest 10-K
3new risk-factor headings
0Form 4 filings reporting open-market purchases (last 180 days)
13Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparing 10-K filed 2026-02-26 (period ending 2025-12-31) with 10-K filed 2025-02-27 (period ending 2024-12-31).

Risk Factors (10-K Item 1A)

17new paragraphs
65removed paragraphs
135reworded paragraphs
34,119 → 30,097words in section

New heading “Our use of artificial intelligence may result in operational disruptions, reputational harm, competitive challenges, regulatory scrutiny, liability, or security risks that could adversely affect our business, financial condition, and results of operations.”

New heading “Strategic investments, partnerships, alliances, or acquisitions, could be difficult to identify, pose integration challenges, divert the attention of management, disrupt our business, dilute stockholder value, and adversely affect our business, financial condition, and results of operations.”

New heading “We cannot guarantee that our share repurchase program will be fully implemented or that such program will enhance the long-term value of the share price of our Class A common stock.”

Removed heading “The use of artificial intelligence could adversely affect our business.”

Removed heading “We derive most of our revenue from sales of our glasses. A decline in sales of our glasses would negatively affect our business, financial condition, and results of operations.”

Removed heading “Acquisitions, strategic investments, partnerships, or alliances could be difficult to identify, pose integration challenges, divert the attention of management, disrupt our business, dilute stockholder value, and adversely affect our business, financial condition, and results of operations.”

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Removed text topics: tariff, write-down, china, regulation
“Efficient inventory management is a key component of our business success and profitability. To be successful, we must maintain sufficient inventory levels to meet our customers’ demands without allowing those levels to increase to such an extent that the costs to our or our third-party optical laboratories, retail stores and other points of distribution that hold the goods unduly impact our financial results. …”
see in full comparison
Removed text topics: china, supply chain, regulation, pandemic
“Moreover, volatile economic conditions may make it more likely that our suppliers and logistics providers may be unable to timely deliver supplies, or at all, and there is no guarantee that we will be able to timely locate alternative suppliers of comparable quality at an acceptable price. In addition, international supply chains have been and may in the future be impacted by events outside of our control, including but not limited to global pandemics and geopolitical conflicts, and limit our ability to procure timely delivery of supplies or finished goods and services. …”
see in full comparison
New text topics: tariff, china, regulation, strike
“We face additional risks related to our international suppliers, especially the optical laboratory we contract with in China and suppliers in China, including port of entry risks such as longshoremen strikes, import restrictions, foreign government regulations, trade restrictions, customs, and duties. In recent years, the U.S. government has implemented tariffs on specified products imported into the United States from China and, in 2025, the U.S. government announced new or heightened tariffs on product imports from certain countries, including China, Italy, Vietnam and Japan. …”
see in full comparison
New text topics: tariff, write-down, china, regulation
“Efficient inventory management is a key component of our business success and profitability. To be successful, we must balance the need to maintain inventory levels that are sufficient to ensure competitive lead times against the risk of inventory obsolescence because of changing customer requirements, fluctuating commodity prices, changes to our products, product transfers, or the life cycle of our products. …”
see in full comparison
Reworded topics: investigation, penalt, breach

Paragraph as it now reads, with added and removed wording marked:

SecurityOur IT and ERP systems and the IT systems of our third-party service providers and business partners may be vulnerable to security incidents compromising the confidentiality, integrity, and availability of thisour information and the security of our IT systemssystems. These incidents could result from cyber-attacks, computer malware, viruses, social engineering (including spear phishing and ransomware attacks), credential stuffing, supply chain attacks, efforts by individuals or groups of hackers and sophisticated organizations, including state-sponsored organizations, errors or malfeasance of our personnel, malicious code embedded in open-source software, misconfigurations, “bugs”, human or technological errors, and other security vulnerabilities in the software or systems on which we rely. We anticipate that these threats will continue to grow in scope and complexity over time and such incidents have occurred in the past, and may occur in the future, resulting in unauthorized, unlawful, or inappropriate access to, inability to access, disclosure of, or loss of the sensitive, proprietary, personal and confidential information that we handle.handle, Forincluding example,health ininformation, 2018,credit we experienced a credential stuffing attack in which malicious third parties likely used credentials compromised in data breaches suffered by other, unaffiliated companies to access accounts on our platform. In 2019, we received notice from the Office for Civil Rights, or OCR, of the U.S. Department of Healthcard and Humanother Servicespayment indicatingcard that OCR would begin an investigation regarding the incidentinformation, and ourpersonal compliance with the Health Insurance Portability and Accountability Act (“HIPAA”) Privacy, Security, and Breach Notification Rules and requesting certain information related to the incident and our compliance with such rules. The Company paid a civil monetary penalty to OCR in December 2024 and the investigation was formally closed in February 2025.information.
see in full comparison
New text topics: fine, penalt, recall
“In addition, a government or other regulatory agency could require us or one of our vendors or suppliers to remove a particular product from the market for, among other reasons, failure to adhere to product safety requirements or quality control standards. Product recalls can result in the disposal or write-off of merchandise, harm our reputation, and cause us to lose customers, particularly if those recalls cause consumers to question the performance, quality, safety, or reliability of our products. …”
see in full comparison
Full comparison: every changed paragraph (217)

Green = added, red = removed. Unchanged paragraphs, 3 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Reworded

We have grown rapidly in recent years and have limited experience at our current scale. If we are unable to manage our growth effectively, our brand, company culture, and financial performance may suffer, which may have a material adverse effect on our business, financial condition, and operating results.

Reworded

We have grown rapidly over the last several years, and therefore, ourOur recent growth rates and financial performance should not necessarily be considered indicative of our future performance. For example, our net revenue increased 15.2%13.0% from $669.8 million for the year ended December 31, 2023 to $771.3 million for the year ended December 31, 2024. To effectively manage and capitalize on our growth, we must continue2024 to strengthen$871.9 engagementmillion withfor ourthe existingyear customers,ended growDecember our31, brand awareness, expand our retail footprint, invest in design and technology, expand our vision care offering, and evaluate potential opportunities to expand into new international markets.2025. Our continued growth has in the past, and could in the future, strain our existing resources, and we could experience ongoing operating difficulties in managing our business across numerous jurisdictions, including difficulties in hiring, training, and managing a diffuse and growing employee base. Failure to scale and preserve our company culture with growth could harm our future success, including our ability to retain and recruit personnel and to effectively focus on and pursue our corporate objectives.

Reworded

Moreover, the vertically integrated nature of our business, where we design all of our own glasses in our New York headquarters, contract manufacture all of our glasses frames, fulfill the glasses we sell at our own optical and fulfillment laboratories as well as at third-party contract laboratories, sell our products exclusively through our own retail stores, e-commerce site and mobile application, and service our products,business exposes us to risk and disruption at many points that are critical to successfully operating our business, and may make it more difficult for us to scale our business. If we do not adapt to meet these evolving challenges, or if our management team does not effectively scale with our growth, we may experience erosion to our brand, the quality of our products and services may suffer, and our company culture may be harmed.

Reworded

In addition, the industry for stylish, affordable glasses, as well as for our other optical products and services is rapidly evolving and may not develop as we expect. Overall growth of our net revenue will depend on a number of factors, including those described under “—We may not be successful in our retail growth and vision care expansion strategy.” and “—If we fail to cost-effectively retain our existing customers or to acquire new customers, our business, financial condition, and results of operations would be harmed.” Even if our net revenue continues to increase, our net revenue growth rates may decline in the future as a result of a variety of factors, including macroeconomic factors, increased competition, and the maturation of our business. As a result, you should not rely on our net revenue growth rate for any prior period as an indication of our future performance. Overall growth of our net revenue will depend on a number of factors, including our ability to:

Removed

•price our products and services so that we are able to attract new customers, and expand our relationships with existing customers;

Removed

•accurately forecast our net revenue and plan our operating expenses;

Removed

•successfully compete with other companies that are currently in, or may in the future enter, the industry or the markets in which we compete, and respond to developments from these competitors such as pricing changes and the introduction of new products and services;

Removed

•comply with existing and new laws and regulations applicable to our business;

Removed

•successfully expand in existing geographic markets and enter new geographic markets, including international markets;

Removed

•successfully expand and gain market adoption on our market share by offering customers the ability to pay through managed vision care, vision insurance, and other third-party payors;

Removed

•successfully develop new offerings, including new offerings with higher margins, and innovate and enhance our existing products and services and their features, including in response to new trends, competitive dynamics, or the needs of customers;

Removed

•successfully identify and acquire or invest in businesses, products, or technologies that we believe could complement or expand our business;

Removed

•avoid interruptions or disruptions in distributing our products and services;

Removed

•provide customers with a high-quality experience and customer service and support that meets their needs;

Removed

•hire, integrate, and retain talented sales, customer experience, product design, and development and other personnel, including vision care professionals;

Removed

•expand vision care services provided by optometrists employed either by us or by independent professional corporations or similar entities or with whom we have contractual arrangements;

Removed

•effectively manage growth of our business, personnel, and operations, including new retail store openings;

Removed

•effectively manage our costs related to our business and operations, including increased costs related to tariffs; and

Removed

•maintain and enhance our reputation and the value of our brand.

Removed

Because we have a limited history operating our business at its current scale, it is difficult to evaluate our current business and future prospects, including our ability to plan for and model future growth. Our limited operating experience at this scale, combined with the rapidly evolving nature of the market in which we sell our products and services, substantial uncertainty concerning how these markets may develop, and other economic factors beyond our control, reduces our ability to accurately forecast quarterly or annual revenue. Failure to manage our future growth effectively could have an adverse effect on our business, financial condition, and operating results.

Reworded

We also expectintend to continueinvest heavily in growth, but unforeseen expenses or ineffective resource allocation could lead to expendlosses. substantial financial and other resources to grow our business, andIf we may fail to allocatemanage our resources in a manner that results in increased net revenuefuture growth in our business. Additionally, we may encounter unforeseen operating expenses, difficulties, complications, delays, and other unknown factors that may result in losses in future periods. If our net revenue growth does not meet our expectations in future periods,effectively, our business, financial condition, and results of operations may be harmed, and we may not achieve or sustain profitability in the future.

Reworded

Our growth strategy contemplates a significant expansion of our retail store footprint and the expansion of our vision care services. For example, we opened our first permanent retail store in New York in 2013 and have since grown to 276323 retail stores across the United States and Canada as of December 31, 2024,2025, of which 236285 offered in-person eye exams. Our ability to expand our vision care services depends on our ability to attract and retain optometrists, opticians and other vision care professionals. See “—Failure to recruit and retain optometrists, opticians, and other visioneye care professionals for our retail stores could materially adversely affect our business, financial condition, and results of operations.” Further, as we increase the scope of services that we provide and expand in the types of payments we receive from customers from cash-pay to vision plans and health plans, we will increasingly be subject to a number of federal and state healthcare regulatory laws, including federal and state anti-kickback, false claims, self-referral, and other healthcare fraud and abuse laws.

Reworded

•identify and lease retail space with a suitable cost and geographic profile;profile,

Reworded

•construct and open our stores on a timely basis;basis,

Removed

▪negotiate acceptable lease terms at suitable retail locations;

Removed

▪recruit and retain store managers, personnel and qualified vision care professionals (who may be licensed or unlicensed, depending on state regulations) for any new store;

Reworded

▪•address regulatory, competitive, merchandising, marketing, distributionregulatory and otheroperational challenges encountered in connection with expansion into new markets where we have limited historical experience;experience, and

Removed

▪successfully integrate new stores into our existing management structure and operations, including information technology integration; and

Reworded

▪•build awareness of our retail store fleet and vision care offerings through advertising and marketing.

Reworded

IncreasesDisruptions in component costs, shipping costs, long lead times, supply shortages, and supply changes could disruptto our supply chain and factors such as wage rate increases and inflation can have a material adverse effect on our business, financial condition, and operating results.

Added

Meeting customer demand partially depends on our ability to obtain timely and adequate delivery of components for our products and services. We rely on a limited number of third-party suppliers, predominantly outside the United States, for all of the components and materials that go into the manufacturing of our products. We are therefore subject to the risks associated with our suppliers as described under “—We face risks associated with suppliers from whom our products are sourced and are dependent on a limited number of suppliers.”

Removed

Meeting customer demand partially depends on our ability to obtain timely and adequate delivery of components for our products and services. All of the components that go into the manufacturing of our products and services are sourced from a limited number of third-party suppliers predominantly in the U.S., China, Italy, Vietnam, and Japan, and, in particular, over half of the cellulose acetate used to produce many of our frames is provided by a single supplier. Aside from the cellulose acetate that we source ourselves, our contract manufacturers purchase many of these components on our behalf, including sun lenses, demo lenses, hinge and core kits, and branded logos, subject to certain approved supplier lists, and we do not have long-term arrangements with most of our component suppliers. We are therefore subject to the risk of shortages and long lead times in the supply of these components and the risk that our suppliers discontinue or modify components used in our products. In addition, the lead times associated with certain components are lengthy and preclude rapid changes in design, quantities, and delivery schedules. Our ability to meet temporary unforeseen increases in demand has been, and may in the future be, impacted by our reliance on the availability of components from these sub-suppliers. We may in the future experience component shortages, and the predictability of the availability of these components may be limited, which may be heightened in the event of global supply chain disruption. In the event of a component shortage or supply interruption from suppliers of these components, we may not be able to develop alternate sources in a timely manner. Developing alternate sources of supply for these components may be time-consuming, difficult, and costly, and we may not be able to source these components on terms that are acceptable to us, or at all, which may undermine our ability to fill our orders in a timely manner. Any interruption or delay in the supply of any of these parts or components, or the inability to obtain these parts or components from alternate sources at acceptable prices and within a reasonable amount of time, would harm our ability to timely ship our products to our customers. See “—We face risks associated with suppliers from whom our products are sourced and are dependent on a limited number of suppliers.”

Reworded

In addition, substantiallySubstantially all of our components are shipped directly from our contract manufacturers to our optical laboratories in the United States or our third-party optical laboratories in the United States and China, where lenses are cut and mounted into frames. These laboratories process most of the glasses ordered by our customers. Once processed at the laboratories, the finished products are then sorted and shipped using third-party carriers to our retail stores for customer pickup or directly to our customers. Our glasses frames for our Home Try-On program are shipped directly from our contract manufacturers to our third-party distribution center in the United States for shipment directly to our customers. We depend in large part on the orderly operation of this distribution process, which depends, in turn, on adherence to shipping schedules and effective management of our optical laboratory network and third-party distribution center. Increases in transportation costs (including increases in fuel costs), issues with overseas shipments, supplier-side delays, reductions in the transportation capacity of carriers, labor strikes or shortages in the transportation industry, disruptions to the national and international transportation infrastructure, supplier-side delays, and unexpected delivery interruptions or delays also have the potential to derail our distribution process. Moreover, volatile economic conditions and global events, such as geopolitical conflicts, natural disasters, or public health crises, may disrupt our supply chain, potentially preventing us from procuring timely deliveries or securing comparable alternatives at acceptable prices.

Added

We face additional risks related to our international suppliers, especially the optical laboratory we contract with in China and suppliers in China, including port of entry risks such as longshoremen strikes, import restrictions, foreign government regulations, trade restrictions, customs, and duties. In recent years, the U.S. government has implemented tariffs on specified products imported into the United States from China and, in 2025, the U.S. government announced new or heightened tariffs on product imports from certain countries, including China, Italy, Vietnam and Japan. As a result, there is an increase in costs with respect to our products subject to these tariffs. These additional tariffs and the threat of future tariffs, as well as a government’s adoption of “buy national” policies or retaliation by another government against such tariffs or policies have introduced significant uncertainty into the market. Various tariffs enacted in 2025 have been subject to successful legal challenge, but it remains unclear whether and to whom those tariffs may be refunded, and the federal government may attempt to impose new or similar tariffs under alternative statutory mechanisms.

Added

We have implemented mitigation plans and continue to focus on additional mitigation strategies to offset the impact of tariffs, including by continuing to diversify our supplier base in locations outside of China and through selective price increases. If our mitigation efforts to offset the full impact of current and future tariffs are not successful, or if there is a further escalation of tariffs, costs on a significant portion of our products may increase further, which could reduce our margins or force us to further raise prices, and our financial results may be negatively affected. Additionally, deteriorating macroeconomic conditions, including escalating tariffs, could result in increased uncertainty and lead to reduced consumer spending, an economic slowdown or recession, which could in turn negatively affect our business, results of operations and financial condition.

Removed

Moreover, volatile economic conditions may make it more likely that our suppliers and logistics providers may be unable to timely deliver supplies, or at all, and there is no guarantee that we will be able to timely locate alternative suppliers of comparable quality at an acceptable price. In addition, international supply chains have been and may in the future be impacted by events outside of our control, including but not limited to global pandemics and geopolitical conflicts, and limit our ability to procure timely delivery of supplies or finished goods and services. We face additional risks related to the optical laboratory we contract with in China and suppliers in China, including port of entry risks such as longshoremen strikes, import restrictions, foreign government regulations, trade restrictions, customs, and duties.

Removed

We source components from suppliers located in China. In recent years, the U.S. government has implemented tariffs on specified products imported into the United States from China and, as a result, costs with respect to our products subject to these tariffs have increased. In February 2025, the U.S. government imposed additional tariffs on imports from China and announced and subsequently paused implementation of tariffs on imports from Canada and Mexico. These additional tariffs or any future tariffs, as well as a government’s adoption of “buy national” policies or retaliation by another government against such tariffs or policies have introduced significant uncertainty into the market. We have implemented mitigation plans and continue to focus on additional mitigation strategies to offset the impact of tariffs, including by continuing to diversify our supplier base in locations outside of China. If we are unable to mitigate the full impact of current and future tariffs or if there is a further escalation of tariffs, costs on a significant portion of our products may increase further, which could reduce our margins or force us to raise prices, and our financial results may be negatively affected. Further increases in China tariffs will impact our business, and our financial results may also be impacted by any resulting economic slowdown.

Reworded

The inability to fulfill, or any delays in processing, customer orders through our optical laboratory network or any quality issues could result in the loss of customers, issuanceslower ofsales refundsand or credits,profitability, and may also adversely affect our reputation. The success of our retail stores and e-commerce sales depends on the timely receipt of products by our customers and any repeated, intermittent or long-term disruption in, or failures of, the operations of our distribution center and/or optical laboratories could result in lower sales and profitability, a loss of loyalty to our brands, and excess inventory. The insurance we maintain for business interruption may not cover all risk, or be sufficient to cover all of our potential losses, may not continue to be available to us on acceptable terms, if at all, and any insurance proceeds may not be paid to us in a timely manner.

Reworded

We rely heavily on our information technology systems, as well as those of our third-party vendors, business partners, and service providers, for our business to effectively operate and to safeguard confidential information;information. anyAny significant failure, inadequacy, interruption, or cybersecurity incident could adversely affect our business, financial condition, and operations.

Reworded

We rely heavily on our information technology (“IT”) and enterprise resource planning systems (“ERP”), systems, many of which are proprietary, for many functions across our operations, including managing our supply chain and inventory, processing customer transactions in our stores, allocating orders to the appropriate laboratories, our financial accounting and reporting, compensating our employees, and operating our website, mobile applications and in-store systems, including point-of-sale systems. We continuously evaluate our systems landscapelandscape, and we may have tobeen upgradeundertaking a multi-year process of upgrading our IT systemssystems, orincluding implementour newERP technology systems from time to timesystem, in order to support the needs of our business. Costs and potential problems and interruptions associated with such upgrades and implementations, or with maintenance or adequate support of existing IT systems, could disrupt or reduce the efficiency of our operations.

Reworded

Our ability to effectively manage our business and coordinate the manufacturing, sourcing, distribution, and sale of our products depends significantly on the reliability and capacity of these systems. We are critically dependent on the availability, integrity, security, and consistent operations of theseour IT systems, which are highly reliant on the coordination of our internal business and engineering teams. WeWe, and certain of our third party providersproviders, also collect, process, and store sensitive, personal and confidential information, including our proprietary business information and that of our customers, employees, suppliers, and business partners. The secure processing, maintenance, and transmission of this information is critical to our operations. Our and our third party providers’ IT and ERP systems may be subject to damage or interruption from power outages or damages, telecommunications problems, data corruption, software errors, network failures, acts of war or terrorist attacks, fire, flood, global pandemics, and natural disasters; and our existing safety systems, data backup, access protection, user management, and IT emergency planning may not be sufficient to prevent data loss or long-term network outages. Any material disruption or slowdown of our systems or those of our third-party service providers and business partners, could have a material adverse effect on our business, financial condition, and results of operations.

Removed

Our and our third party providers’ IT and ERP systems may be subject to damage or interruption from power outages or damages, telecommunications problems, data corruption, software errors, network failures, acts of war or terrorist attacks, fire, flood, global pandemics, and natural disasters; and our existing safety systems, data backup, access protection, user management, and information technology emergency planning may not be sufficient to prevent data loss or long-term network outages.

Removed

Our IT and ERP systems and the IT systems of our third-party service providers and business partners may be vulnerable to security incidents, attacks by hackers, acts of vandalism, computer viruses, misplaced or lost data, human or technological errors or other similar events. If unauthorized parties gain access to our networks, databases, or other IT systems, or those of our third-party service providers or business partners, they may be able to steal, publish, delete, use inappropriately, or modify our private and sensitive third-party information including health information, credit card and other payment card information, and personal information. In addition, employees may intentionally or inadvertently cause data or security incidents that result in unauthorized access to or release of sensitive, personal or confidential information. Because the techniques used to circumvent security systems can be highly sophisticated, change frequently, are often not recognized until launched against a target, and may originate from less regulated and remote areas around the world, we may be unable to proactively anticipate or address all possible techniques or implement adequate preventive measures for all situations.

Reworded

SecurityOur IT and ERP systems and the IT systems of our third-party service providers and business partners may be vulnerable to security incidents compromising the confidentiality, integrity, and availability of thisour information and the security of our IT systemssystems. These incidents could result from cyber-attacks, computer malware, viruses, social engineering (including spear phishing and ransomware attacks), credential stuffing, supply chain attacks, efforts by individuals or groups of hackers and sophisticated organizations, including state-sponsored organizations, errors or malfeasance of our personnel, malicious code embedded in open-source software, misconfigurations, “bugs”, human or technological errors, and other security vulnerabilities in the software or systems on which we rely. We anticipate that these threats will continue to grow in scope and complexity over time and such incidents have occurred in the past, and may occur in the future, resulting in unauthorized, unlawful, or inappropriate access to, inability to access, disclosure of, or loss of the sensitive, proprietary, personal and confidential information that we handle.handle, Forincluding example,health ininformation, 2018,credit we experienced a credential stuffing attack in which malicious third parties likely used credentials compromised in data breaches suffered by other, unaffiliated companies to access accounts on our platform. In 2019, we received notice from the Office for Civil Rights, or OCR, of the U.S. Department of Healthcard and Humanother Servicespayment indicatingcard that OCR would begin an investigation regarding the incidentinformation, and ourpersonal compliance with the Health Insurance Portability and Accountability Act (“HIPAA”) Privacy, Security, and Breach Notification Rules and requesting certain information related to the incident and our compliance with such rules. The Company paid a civil monetary penalty to OCR in December 2024 and the investigation was formally closed in February 2025.information.

Reworded

While we employ a number of security measures designed to prevent, detect, and mitigate the potential for harm to our business or to our users from security incidents, such as from malicious cyber attacks or theft or misuse of user credentials on our network, these measures may not be effective in every instance. Because the techniques used to circumvent security systems can be highly sophisticated, change frequently, are often not recognized until launched against a target, and may originate from less regulated and remote areas around the world, we may be unable to proactively anticipate or address all possible techniques or implement adequate preventive measures for all situations. The rapid evolution and increased adoption of AI may also make cyber-attacks more difficult to prevent, detect, and mitigate. Attackers are increasingly sophisticated and using techniques and tools, including AI, that can circumvent security controls, evade detection, and remove forensic evidence. Moreover, while we maintain cyber insurance that may help provide coverage for these types of incidents, we cannot assure you that our insurance will be adequate to cover costs and liabilities related to these incidents or that applicable insurance will be available to us in the future on economically reasonable terms or at all. Any such breach, attack, virus, or other event could result in additional costly investigations and litigation exceeding applicable insurance coverage or contractual rights available to us, civil or criminal penalties, operational changes or other response measures, loss of consumer confidence in our security measures, and negative publicity that could adversely affect our business, financial condition, and results of operations.

Reworded

We also rely on a number of third-party service providers to operate our critical business systems, provide us with software, and process confidential, sensitive and personal information, such as the payment processors that process customer credit card payments, which expose us to security risks outside of our direct controlcontrol, and our ability to monitor these third-party service providers’ data security is limited. Certain of our vendors have experienced security incidents in the past, and we expect that other vendors or third-party service providers will experience security incidents in the future that could compromise the confidentiality, integrity, or availability of the systems they operate for us or the information they process on our behalf. Cybercrime and hacking techniques are constantly evolving, and we or our third-party service providers may be unable to anticipate attempted security breaches, react in a timely manner, or implement adequate preventative measures, particularly given the increasing use of hacking techniques designed to circumvent controls, avoid detection, and remove or obfuscate forensic artifacts. While we have taken measures designed to protect the security of the IT systems and confidential and personal information under our control, weWe cannot ensure that any security measures that we or our third-party service providers have implemented will be effective against current or future security threats. Moreover, we or our third-party service providers may be more vulnerable to such attacks in remote work environments,environments. which have increased since the COVID-19 pandemic. Because we make extensive use of third-party suppliers and service providers, such as cloud services that support our internal and customer-facing operations, successfulSuccessful cyberattacks that disrupt or result in unauthorized access to third party IT systems can materially impact our operations and financial results. There can be no assurance that our cybersecurity risk management program and processes, including our policies, controls or procedures, will be fully implemented, complied withwith, or effective in protecting our systems and information.

Reworded

A security breachincident may also cause us to breach our contractual obligations. Our agreements with certain customers, business partners, or other stakeholders may require us to use industry-standard or reasonable measures to safeguard confidential, sensitive and personal information. As a healthcare provider and to the extent we provide services to healthcare providers, we are also subject to laws and regulations such as the Health Insurance Portability and Accountability Act (“HIPAA”) Security Rule that require us to adhere to specific technical safeguards, or to use industry-standard or reasonable security measures to safeguard certain information. A security incident could lead to claims by our customers, business partners, or other relevant stakeholders that we have failed to comply with such legal or contractual obligations. In addition, our inability to comply with data privacy or security obligations in our contracts or our inability to flow down such obligations to our vendors, collaborators, other contractors, or consultants may cause us to breach our contracts. As a result, we could be subject to legal action or our customers or business partners could end their relationships with us. There can be no assurance that the limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us from liabilities or damages.

Reworded

The cost of investigating, mitigating, and responding to potential security breaches and complying with applicable breach notification obligations to individuals, regulators, partners, and others can be significant. Further, defending a suit, regardless of its merit, could be costly, divert management attention, and harm our reputation. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could adversely affect our reputation, business, financial condition, revenues, results of operations, or cash flows. Any material disruption or slowdown of our systems or those of our third-party service providers and business partners, could have a material adverse effect on our business, financial condition, and results of operations. Our risks are likely to increase as we continue to expand, grow our customer base, and process, store, and transmit increasing amounts of confidential, proprietary and sensitive information.

Added

Our use of artificial intelligence may result in operational disruptions, reputational harm, competitive challenges, regulatory scrutiny, liability, or security risks that could adversely affect our business, financial condition, and results of operations.

Removed

The use of artificial intelligence could adversely affect our business.

Reworded

We use artificial intelligenceAI for certain business purposes, including the automation of certain tasks, predicting market trends, and improving our customer experience.experience, Weand maydeploying expand our use of artificial intelligence in other areas of our business, including incertain customer facing applications. We are also developing products and services that integrate AI, such as the AI-powered smart glasses we are developing with Google.

Reworded

Issues relating to our use of new technologies such as artificial intelligence may cause us to experience operational disruptions, negative publicity and reputational harm, competitive harm, criminal and civil liability and new or enhanced regulatory scrutiny, or criminal and civil liability, and to incur additional costs to resolve such issues. For example, artificial intelligence is based on predictive analytics, which can include unexpected biases and lead to discriminatory outcomes. In addition, if we use protected health information (“PHI”) for our artificial intelligence technologies, we must have rights and permissions to do so from our customers. If we do not have rights or permissions to use PHI or to de-identify PHI or if we do not de-identify PHI in accordance with HIPAA’s safe harbor method, and use PHI or de-identified PHI for such purposes, we may be subject to civil and criminal liability or other actions.

Reworded

Further, perceived or actual technical, legal, privacy, security, ethicalethical, or other issues relating to the use of artificial intelligence could undermine the decisions, predictions, analysis or other output that such tools produce and create additional risks, such as risks of cybersecurity incidents. Additionally, any integration of artificial intelligence in our or our third-party service providers’ operations, products or services is expected to pose new or unknown cybersecurity risks and challenges. Further, use of artificial intelligence platforms by our employees, whether authorized or unauthorized, may also increase the risk that our proprietary information will be unintentionally disclosed or undermine our claims to certain intellectual property. Any of the foregoing, as well our failure to responsibly deploy artificial intelligence in our operations or the failure of artificial intelligence systems,operations, could adversely affect the performance of our products and services and our business, financial condition and results of operations.

Reworded

The growth of our business is dependent upon our ability to continue to grow by cost-effectively retaining our existing customers, increasing their average order volume (“AOV”), defined as net revenue for a given period divided by the number of orders during the same period, and adding new customers. Although we believe that many customers originate from word-of-mouth and other non-paid referrals, weWe expect to continue to expend resources and run marketing campaigns to acquire additional customers, all of which could impact our overall profitability. If we are not able to continue to expand our customer base, increase their AOV or fail to retain customers, our net revenue may grow slower than expected or decline.

Reworded

The growth of our e-commerce channel is also critical to our continued customer retention and growth. Historically, consumers have been slower to adopt online shopping for glasses and contact lenses than e-commerce offerings in other industries such as consumer electronics and apparel. Improving upon the consumer in-store experience through an online platform is difficult due to broad consumer demands on selection, quality, convenience, and affordability.lenses. Changing traditional optical retail habits is difficult, and if consumers and retailers do not embrace online optical retail as we expect, our business and operations could be harmed. Moreover, even if more consumers begin to shop for glasses and contacts online, if we are unable to address their changing needs and anticipate or respond to market trends and new technologies, including the integration of artificial intelligence and machine learning,intelligence, in a timely and cost-efficient manner, we could experience increased customer churn, which, in turn, would adversely affect our business and results of operations.

Reworded

•the success of our marketing and advertising efforts; or

Removed

•unpredictable nature of the impact of a pandemic, an outbreak of disease or similar public health crisis;

Reworded

•deteriorating macroeconomic conditions and reduced customer spending;spending.

Removed

•changes in availability of our historic or current customer acquisition methods; or

Removed

•dissatisfaction with changes we make to our products and services.

Showing the first 60 of 217 changed paragraphs. The complete comparison will be part of Pro (coming soon). Meanwhile you can read the full text in the original filing.

Management's Discussion & Analysis (MD&A) (10-K Item 7)

22new paragraphs
24removed paragraphs
24reworded paragraphs
6,632 → 6,483words in section

New heading “Recent Business Developments”

New heading “Comparison of the Years Ended December 31, 2025 and 2024”

New heading “Share Repurchase Program”

Removed heading “Comparison of the Years Ended December 31, 2023 and 2022”

Removed heading “Credit Facility”

Removed heading “2022 Credit Facility”

Removed heading “Stock-Based Compensation”

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Removed text topics: tariff, supply chain, inflation, interest rate
“The nature of our business, which involves the sale of products and services that are a medical necessity for many consumers, provides some insulation from swings in consumer sentiment and general economic conditions. However, our performance and growth are still impacted by these factors. Elevated inflation and interest rates, tariffs, and other negative economic factors may impact consumer spending habits as well as our cost of attracting and our ability to attract new customers. …”
see in full comparison
New text topics: tariff, china
“Our 2025 results were affected by cost volatility related to evolving international trade policies and tariffs. We have taken proactive steps to manage these costs, including further diversifying our supplier base outside of China, making strategic price adjustments on select products, and disciplined expense management. The complexity of the global trade landscape makes it difficult to predict the timing and extent of future policy changes.”
see in full comparison
New text topics: ai, labor
“In the second quarter of 2025, we announced a partnership with Google to develop AI-enabled glasses intended for all-day wear. We are working closely with Google on the development of AI glasses and intend to launch a series of products over time. As part of this collaboration, Google has committed up to $75 million for our product development and commercialization costs. In addition, Google has committed to investing up to $75 million in Warby Parker, at our option and subject to reaching certain collaboration milestones. …”
see in full comparison
New text topics: inflation, interest rate
“The nature of our business, which involves the sale of products and services that are a medical necessity for many consumers, provides some insulation from swings in consumer sentiment. However, our performance and growth are still subject to broader macroeconomic factors. During 2025, we experienced pressure from a dynamic trade environment and fluctuating inflationary trends, which impacted both consumer discretionary spending and our internal cost structure. …”
see in full comparison
New text topics: supply chain, labor
“We believe our business model, which emphasizes an outstanding value-driven experience, provides a durable foundation. Our ongoing efforts to expand our supply chain network, both through international frame manufacturing partnerships and our domestic optical laboratories, are a key strategy intended to insulate us from localized disruptions. While we continue to navigate these macroeconomic uncertainties, we remain committed to meeting growing customer demand while maintaining our exceptional quality and customer satisfaction standards.”
see in full comparison
New text
“Comparison of the Years Ended December 31, 2025 and 2024”
see in full comparison
Full comparison: every changed paragraph (70)

Green = added, red = removed. Unchanged paragraphs, 6 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Reworded

You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K (“Form 10-K”).10-K. This discussion and other parts of this Annual Report on Form 10-K contain forward-looking statements, such as those relating to our plans, objectives, expectations, intentions, and beliefs, which involve risks and uncertainties. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the sections titled “Special Note Regarding Forward-Looking Statements” and “Risk Factors” included elsewhere in this Annual Report on Form 10-K.

Reworded

We generate revenue through selling our wide array of prescription and non-prescription eyewear, including glasses, sunglasses, and contact lenses. We also generate revenue from providing eye exams and vision tests, and selling eyewear accessories. We maintain data across the entire customer journey that allows us to develop deep insights, informing our innovation priorities and enabling us to create a highly personalized, brand-enhancing experience for our customers. We have built an integrated, omnichannel presence that we believe deepens our relationship with existing customers while broadening reach and accessibility. And while we have the ability to track where our customers transact, we’re channel agnostic to where the transaction takes place and find that many of our customers engage with us across both digital and physical channels; for example, many customers who check out online also visit a store throughout their customer journey, while others choose to browse online before visiting one of our stores.

Removed

•we generated net revenue of $771.3 million, $669.8 million, and $598.1 million, respectively;

Removed

•we generated gross profit of $426.8 million, $365.2 million, and $341.1 million, respectively, representing a gross profit margin of 55.3%, 54.5%, and 57.0%, respectively;

Reworded

•we generated net lossrevenue of $20.4$871.9 million, $63.2$771.3 million, and $110.4$669.8 million, respectively; and

Reworded

•we generated Adjustedgross EBITDAprofit of $73.1$470.6 million, $52.4$426.8 million, and $27.2$365.2 million, respectively.respectively, representing a gross margin of 54.0%, 55.3%, and 54.5%, respectively;

Added

•we generated net income of $1.6 million, and net loss of $20.4 million and $63.2 million, respectively; and

Added

•we generated Adjusted EBITDA of $95.2 million, $73.1 million, and $52.4 million, respectively, representing an Adjusted EBITDA Margin of 10.9%, 9.5%, and 7.8%, respectively.

Reworded

For a definitiondefinitions of Adjusted EBITDA,EBITDA aand Adjusted EBITDA Margin, non-GAAP measure,measures, and a reconciliation to the most directly comparable GAAP measure, see the section titled “Key Business Metrics and Certain Non-GAAP Financial Measures.”

Added

Recent Business Developments

Added

In the second quarter of 2025, we announced a partnership with Google to develop AI-enabled glasses intended for all-day wear. We are working closely with Google on the development of AI glasses and intend to launch a series of products over time. As part of this collaboration, Google has committed up to $75 million for our product development and commercialization costs. In addition, Google has committed to investing up to $75 million in Warby Parker, at our option and subject to reaching certain collaboration milestones. During the year ended December 31, 2025, the Company reduced selling, general, and administrative expenses by $3.3 million related to costs which are reimbursable by Google and are thus fully offset within the period.

Added

The nature of our business, which involves the sale of products and services that are a medical necessity for many consumers, provides some insulation from swings in consumer sentiment. However, our performance and growth are still subject to broader macroeconomic factors. During 2025, we experienced pressure from a dynamic trade environment and fluctuating inflationary trends, which impacted both consumer discretionary spending and our internal cost structure. While elevated interest rates and government policy continue to influence consumer confidence, we remain focused on our core value proposition to mitigate these headwinds.

Added

Our 2025 results were affected by cost volatility related to evolving international trade policies and tariffs. We have taken proactive steps to manage these costs, including further diversifying our supplier base outside of China, making strategic price adjustments on select products, and disciplined expense management. The complexity of the global trade landscape makes it difficult to predict the timing and extent of future policy changes.

Added

We believe our business model, which emphasizes an outstanding value-driven experience, provides a durable foundation. Our ongoing efforts to expand our supply chain network, both through international frame manufacturing partnerships and our domestic optical laboratories, are a key strategy intended to insulate us from localized disruptions. While we continue to navigate these macroeconomic uncertainties, we remain committed to meeting growing customer demand while maintaining our exceptional quality and customer satisfaction standards.

Removed

The nature of our business, which involves the sale of products and services that are a medical necessity for many consumers, provides some insulation from swings in consumer sentiment and general economic conditions. However, our performance and growth are still impacted by these factors. Elevated inflation and interest rates, tariffs, and other negative economic factors may impact consumer spending habits as well as our cost of attracting and our ability to attract new customers. We believe our business model, focused on providing an exceptional value and experience to our customers, will help mitigate the impact of many of these macroeconomic factors, however, the extent of such mitigation and the impact on future results is uncertain. We also continue to diversify and expand our supply chain network, both internationally with our frame manufacturers and domestically with our wholly owned and partner optical laboratories, which we believe helps to insulate us from supply chain disruption and allowed us to continue to meet growing customer demand over the last several years while maintaining our exceptional quality and customer satisfaction standards.

Reworded

__________________ (1)Store Count number at the end of the period indicated.

Reworded

(2)Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures. For more information regarding our use of these measures and a reconciliation of net income (loss) to Adjusted EBITDA and Adjusted EBITDA Margin, see the section titled "Adjusted EBITDA and Adjusted EBITDA Margin” below.

Reworded

We have thoughtfully expanded our retail store footprint over the past several years. During the years ended December 31, 2025, 2024, 2023, and 2022,2023, we opened 47, 39, 37, and 3937 net new retail stores, respectively. As of December 31, 2025, 285 out of our 323 retail stores offered in-person eye exams, representing 88.2% of our fleet, compared to 85.5% and 81.9% as of December 31, 2024 and 2023, respectively.

Removed

As of December 31, 2024, 236 out of our 276 retail stores offered in-person eye exams.

Reworded

By providing these non-GAAP financial measures, together with a reconciliation to the most directly comparable GAAP measure, we believe we are enhancing investors’ understanding of our business and our results of operations, as well as assisting investors in evaluating how well we are executing our strategic initiatives. Adjusted EBITDA and Adjusted EBITDA Margin have limitations as analytical tools, and should not be considered in isolation, or as an alternative to, or a substitute for net income (loss) or other financial statement data presented in our consolidated financial statements as indicators of financial performance. Some of the limitations are:

Reworded

The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to the most directly comparable GAAP measure, which is net income (loss):

Reworded

__________________ (1) Represents expenses related to the Company’s equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions, as well as the issuance of 48,486 shares of Class A common stock to charitable donor advised funds in February 2024. Included in stock-based compensation expense for the year ended December 31, 2023 is $2.2 million of liability based awards resulting from accrued bonuses that were settled in equity in the first quarter of 2024.conditions. For the years ended December 31, 2025, 2024, 2023, and 2022,2023, the amount includes $1.1$1.6 million, $0.6$1.1 million, and $0.6 million of employer payroll costs associated with releases of RSUs and option exercises, respectively.

Reworded

(2) Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in each of May 2025, May 2024, and August 2023 and May 2022 to the Warby Parker Impact Foundation, and 56,938 shares of Class A common stock to charitable donor advised funds in June 2023, and 34,528 shares of Class A common stock to charitable donor advised funds in November 2022.2023.

Removed

(3) Represents the amortization of costs capitalized in connection with the implementation of cloud-based software.

Reworded

(43) Represents internal and external non-capitalized costs related to the implementation of ourmajor new Enterpriseenterprise Resourcesoftware Planning (“ERP”) system.systems.

Added

(4) Represents one-time inventory write-downs primarily related to the decision in the second quarter of 2025 to sunset our Home-Try On program at the end of 2025.

Reworded

(5) RepresentsPrimarily employeerepresents severancerestructuring costs incurred in the second quarter of 2025 and relatedthe costsfourth forquarter restructuring actions executed in Octoberof 2024 and August 2022 and charges for certain legal matters outside the ordinary course of business.

Reworded

We primarily derive revenue from the sales of eyeweareyewear, products,contact optical serviceslenses, and accessories.eye care. We sell products and services through our stores, website, and mobile apps. Revenue generated from eyewear includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, lens replacements, and customer charges for optional expedited shipping. Revenue generated from visioneye care consists of in-person eye exams and prescriptions issued through the Virtual Vision Test app. Revenue from products is recognized when the customer takes possession of the product, either at the point of delivery or in-store pickup, and is recorded net of returns and discounts. Revenue for services is recognized when the service is rendered and is recorded net of discounts.

Added

Cost of goods sold includes the costs incurred to acquire materials, assemble, and sell our finished products.

Reworded

Cost of goods sold includes the costs incurred to acquire materials, assemble,assemble and sell our finished products.products, purchase and fulfill contacts orders through our third-party distribution partner, and provide eye exams. Such costs include (i) product costs, including freight and import costs and adjustments to the lesser of cost and net realizable value, (ii) optical laboratory costs, (iii) customer shipping, (iv) occupancy and depreciation costs of retail stores, and (v) employee-related costs associated with eye exams, which includes salaries, benefits, bonuses, and stock-based compensation. We expect our cost of goods sold to fluctuate as a percentage of net revenue primarily due to product mix, customer preferences and resulting demand, the cost and management of inventory, shipping costs, laboratory utilization, and the scaling of our eye exam and contacts businesses. Cost of goods sold also may change as we open or close retail stores because of the resulting change in related occupancy and depreciation costs.

Reworded

Provision for income taxes consists of income taxes related to foreign and domestic federal and state jurisdictions in which we conduct business, adjusted for allowable credits, deductions, and valuation allowance against deferred tax assets. We expect our provision to fluctuate based on changes in our operations, our income before taxes, and tax laws or regulations.

Added

Comparison of the Years Ended December 31, 2025 and 2024

Added

Net revenue increased $100.6 million, or 13.0%, for the year ended December 31, 2025 compared to the same period in 2024. Driving this increase was our 47 new stores opened in 2025, a 7.0% increase in our Active Customers, and a 5.7% increase in Average Revenue per Customer to $324, from $307 in the prior year period. Average Revenue per Customer growth was primarily driven by our glasses business, which benefited from strong adoption of precision progressives and selective price increases during the second quarter, as well as by growth in our contacts and eye exam businesses which are often purchased together with glasses.

Added

Cost of goods sold increased by $56.8 million, or 16.5%, for the year ended December 31, 2025 compared to the same period in 2024, and increased as a percentage of revenue over the same period by 130 basis points, from 44.7% of revenue to 46.0% of revenue. The increase in cost of goods sold was primarily driven by increased product and fulfillment costs associated with our sales growth, particularly related to the growth in our contact lens offering and optical laboratory costs to support glasses growth, as well as increases in store occupancy costs and doctor headcount due to new retail stores.

Added

Gross profit, calculated as net revenue less cost of goods sold, increased by $43.7 million, or 10.2%, for the year ended December 31, 2025 compared to the same period in 2024, primarily due to the increase in net revenue over the same period.

Added

Gross margin, expressed as a percentage and calculated as gross profit divided by net revenue, decreased by 130 basis points for the year ended December 31, 2025 compared to the same period in 2024. The decrease in gross margin was primarily driven by tariff costs related to glasses, sales growth of contact lenses, which are sold at a lower margin than our other eyewear, increased doctor headcount as the number of exam stores grew by 21%, and increased customer shipping costs as a percent of revenue, partially offset by selective price increases in glasses taken in the second quarter and increased penetration of progressives and other lens enhancements.

Added

Selling, general, and administrative expenses increased $19.0 million, or 4.2%, for the year ended December 31, 2025 compared to the same period in 2024. This increase was primarily driven by higher payroll related costs from growth in our retail workforce and investments in marketing, partially offset by lower stock-based compensation, mostly related to the 2021 Founders Grant. As a percentage of revenue, SG&A decreased by 460 basis points, primarily driven by slower growth in corporate expenses, efficiencies in our customer experience operations, and reduced stock-based compensation.

Added

Interest and other income, net decreased by $2.2 million, or 20.9%, for the year ended December 31, 2025 compared to the same period in 2024 primarily due to unfavorable fluctuations in foreign currency rates and lower interest rates on our increased cash and cash equivalents balance.

Added

Provision for income taxes increased $0.5 million, or 60.2%, for the year ended December 31, 2025 compared to the same period in 2024 primarily due to the change in pre-tax income (loss) in addition to the tax effects of stock-based compensation expense and depreciation expense.

Reworded

Selling, general, and administrative expenses increased $19.7 million, or 4.5%, for the year ended December 31, 2024 compared to the same period in 2023. This increase was primarily driven by higher payroll-related costs, primarily from growth in our retail workforce, and investments in marketing, partially offset by a $23.2 million decrease in stock-based compensation, mostly related to the 2021 Founders Grant (as described in Note 7 to our consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K).

Removed

Comparison of the Years Ended December 31, 2023 and 2022

Removed

Net revenue increased $71.7 million, or 12.0%, for the year ended December 31, 2023 compared to the same period in 2022. The growth in net revenue was primarily driven by an increase in Average Revenue per Customer, to $287 from $263 in the prior year period, as well as a 2.5% increase in Active Customers. Average Revenue per Customer growth was driven by an increase in units per order as customers took advantage of our bundling promotions and also purchased contacts or eye exams along with glasses in the same transaction.

Removed

Cost of goods sold increased by $47.5 million, or 18.5%, for the year ended December 31, 2023 compared to the same period in 2022, and increased as a percentage of revenue over the same period by 250 basis points, from 43.0% of revenue to 45.5% of revenue. The increase in cost of goods sold was primarily driven by increased product and fulfillment costs associated with the growth in our contact lens offering and optical laboratory utilization, as well as an increase in store occupancy costs, including depreciation, and prescription services expenses due to new retail stores and optical exam rooms that opened in 2023.

Removed

Gross profit, calculated as net revenue less cost of goods sold, increased by $24.2 million, or 7.1%, for the year ended December 31, 2023 compared to the same period in 2022, primarily due to the increase in net revenue over the same period.

Removed

Gross margin, expressed as a percentage and calculated as gross profit divided by net revenue, decreased by 250 basis points for the year ended December 31, 2023 compared to the same period in 2022. The decrease in gross margin was primarily driven by the sales growth of contact lenses which are sold at a lower margin than our other eyewear, increased doctor salaries, as the number of stores offering eye exams grew, and increases in store occupancy costs as a percent of revenue as we grew our store base from 200 stores as of December 31, 2022 to 237 stores as of December 31, 2023. These impacts were partially offset by increased progressives penetration, increased efficiencies in our owned optical laboratories, and lower outbound customer shipping costs as a percent of revenue.

Removed

Selling, general, and administrative expenses decreased $15.0 million, or 3.3%, for the year ended December 31, 2023 compared to the same period in 2022. This decrease was primarily driven by a $27.7 million decrease in stock-based compensation, mostly related to the Founders Grant (as described in Note 7 to our consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K), and lower marketing costs, including costs associated with our Home Try-On program, in the first half of the year, which decreased to 12% of revenue in the year ended December 31, 2023 compared to 14% in the same period of 2022. The decrease was partially offset by increased technology costs, mainly driven by the implementation of our new ERP system, and higher compensation costs from growth in our retail workforce.

Removed

Interest and other income, net increased by $7.9 million, or 606.4%, for the year ended December 31, 2023 compared to the same period in 2022 primarily due to higher interest rates on our cash and cash equivalents balance.

Removed

Provision for income taxes decreased $0.1 million, or 12.9%, for the year ended December 31, 2023 compared to the same period in 2022 primarily due to the 2022 establishment of a valuation allowance on our Canadian subsidiary, partially offset by higher state tax expense in 2023.

Removed

Credit Facility

Removed

2022 Credit Facility

Removed

In September 2022, the Company and its wholly owned subsidiary, Warby Parker Retail, Inc. (together, the “Borrowers”), entered into a Credit Agreement with Comerica Bank and the lenders from time to time party thereto (as amended, the “2022 Credit Facility”). The 2022 Credit Facility consisted of a $100.0 million five-year revolving credit facility with sublimits of $15.0 million for letters of credit and $5.0 million for swing line notes. In February 2024, the 2022 Credit Facility was terminated and replaced by the 2024 Credit Facility as described below.

Reworded

In February 2024, the Company and its wholly owned subsidiary, Warby Parker Retail, Inc. (together, the “Borrowers”) entered into a Credit Agreement with JPMorgan Chase Bank, N.A. and the lenders party thereto (the “2024 Credit Facility”), which replaced thea 2022previous Creditcredit Facility.facility. The 2024 Credit Facility consists of a $120.0 million five-year revolving credit facility with sublimits of $15.0 million for letters of credit and $10.0 million for swingline loans. The 2024 Credit Facility includes an option for the Company to increase the available amount by up to $55.0 million, for a maximum borrowing capacity of $175.0 million, subject to the consent of the lenders funding the increase and certain other conditions. Proceeds of the borrowings under the 2024 Credit Facility are expected to be used for working capital and other general corporate purposes in the ordinary course of business. The Company is permitted to repay borrowings under the 2024 Credit Facility at any time, in whole or in part, without penalty.

Added

Share Repurchase Program

Added

In February 2026, the Company’s Board of Directors authorized a share repurchase program to purchase up to $100.0 million of the Company’s Class A common stock (the “Share Repurchase Program”). Repurchases under the Share Repurchase Program may be made in the open market, in privately negotiated transactions, or otherwise, with the amount and timing of repurchases to be determined at the Company’s discretion, depending on market conditions and corporate needs. Open market repurchases will be structured to occur in accordance with applicable federal securities laws, including within the pricing and volume requirements of Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The Company may also, from time to time, enter into Rule 10b5-1 plans to facilitate repurchases of its shares under this authorization. The Share Repurchase Program does not have a fixed expiration date, does not obligate the Company to acquire any particular amount of Class A common stock, and may be modified, suspended, or terminated at any time at the discretion of the Company’s Board of Directors.

Added

Net cash provided by operating activities was $110.8 million for the year ended December 31, 2025, consisting of a net income of $1.6 million, adjusted for $91.6 million of non-cash expenses and $17.6 million of net cash from changes in operating assets and liabilities. The non-cash charges included $34.5 million of stock-based compensation, $50.3 million of depreciation and amortization, $3.4 million of amortization of cloud-based implementation costs, $2.8 million of non-cash charitable contributions, and $0.6 million of non-cash impairment charges. The changes in operating assets and liabilities were primarily driven by increases in accounts payable and lease liabilities and a decrease in inventory, partially offset by an increase in prepaid expenses and other assets.

Removed

Net cash provided by operating activities was $10.4 million for the year ended December 31, 2022, consisting of a net loss of $110.4 million, adjusted for $135.5 million of non-cash expenses and $14.7 million of net cash used as a result of changes in operating assets and liabilities. The non-cash charges included $98.0 million of stock-based compensation, $31.9 million of depreciation and amortization, $3.8 million of non-cash charitable contributions, $1.6 million of non-cash impairment charges, and $0.2 million of amortization of cloud-based implementation costs. The changes in operating assets and liabilities were primarily driven by increases in net inventory to support the growth of our business, prepaid expenses and other assets, other non-current assets, and a net decrease in accounts payable and accrued expenses, partially offset by increases in net lease liabilities in connection with net retail leases entered into in 2022 and deferred revenue.

Added

For the year ended December 31, 2025, net cash used in investing activities was $67.0 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores and investments in capitalized software development costs.

Reworded

For the year ended December 31, 2023, net cash used in investing activities was $54.7 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail storesstores, andinvestments in capitalized software development costs, and an investment in a private optical equipment company.

Removed

For the year ended December 31, 2022, net cash used in investing activities was $60.2 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores, as well as investments in our supply chain infrastructure and capitalized software development costs.

Reworded

For the year ended December 31, 2024,2025, net cash providedused byin financing activities was $5.0$12.0 million, which was primarily related to cash paid for shares withheld for taxes for stock-based compensation, partially offset by proceeds from stock option exercises, shares issued in connection with our Employee Stock Purchase Plan (“ESPP”), and other equity activity..

Showing the first 60 of 70 changed paragraphs. The complete comparison will be part of Pro (coming soon). Meanwhile you can read the full text in the original filing.

What changed in the latest 10-Q

Comparing 10-Q filed 2026-08-06 (period ending 2026-06-30) with 10-Q filed 2026-05-07 (period ending 2026-03-31).

Risk Factors (10-Q Part II, Item 1A)

0new paragraphs
0removed paragraphs
0reworded paragraphs
95 → 95words in section

The section in the latest 10-Q reads in full:

There have been no material changes to the risk factors affecting our business, financial condition, or future results from those set forth in Part I, Item 1A, Risk Factors, in the Annual Report. However, you should carefully consider the factors discussed in the Annual Report and in this Quarterly Report on Form 10-Q, which could materially affect our business, financial condition or future results. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

No wording changes found in this section.

Full comparison: every changed paragraph (0)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Management's Discussion & Analysis (MD&A) (10-Q Part I, Item 2)

21new paragraphs
0removed paragraphs
30reworded paragraphs
5,485 → 6,361words in section

New heading “Comparison of the Six Months Ended June 30, 2026 and 2025”

New heading “Cost of Goods Sold, Gross Profit, and Gross Margin”

New heading “Selling, General, and Administrative Expenses”

New heading “Interest and Other Income, Net”

New heading “Provision for Income Taxes”

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Reworded topics: tariff, write-down, labor

Paragraph as it now reads, with added and removed wording marked:

Gross margin, expressed as a percentage and calculated as gross profit divided by net revenue, decreasedincreased by 230490 basis points for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025. The decreaseincrease was primarily drivenrelated to a 500 basis point benefit from IEEPA tariff refunds as well as 110 basis points from the one-time inventory write-downs in Q2 2025 related to the sunset of our Home Try-On program. These benefits were partially offset by deleverage in the fixed expenses portion of gross margin, which includes doctor headcount and occupancy, the impact of tariff costs related to glasses, and increased optical laboratory and customer shipping costs. These impacts were partially offset by selective price increases implemented during the second quarter of 2025, and increased penetration of higher margin progressive lenses and other lens enhancements.occupancy.
see in full comparison
Reworded topics: tariff, labor

Paragraph as it now reads, with added and removed wording marked:

Cost of goods sold increaseddecreased by $13.6$1.8 million, or 13.9%,1.8%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, and increaseddecreased as a percentage of revenue over the same period, from 43.7%47.0% of revenue to 46.0%42.1% of revenue. The increasedecrease in cost of goods sold was primarily driven by increased product and fulfillment costs associated with our sales growth, particularly related to opticalthe laboratorybenefit andfrom lensIEEPA costs,tariff andrefunds, partially offset by increases in store occupancy costs and doctor headcount due to new retail stores.
see in full comparison
New text
“Comparison of the Six Months Ended June 30, 2026 and 2025”
see in full comparison
New text
“Cost of Goods Sold, Gross Profit, and Gross Margin”
see in full comparison
New text
“Selling, General, and Administrative Expenses”
see in full comparison
New text topics: tariff
“During the three and six months ended June 30, 2026, the Company determined that the receipt of refunds totaling $14.4 million of IEEPA tariffs were probable and recorded an $11.8 million benefit to cost of goods sold for inventory sold through June 30, 2026 and a $2.6 million reduction to inventory that will be recorded through cost of goods sold as inventory turns in the second half of 2026. The Company recorded interest income of $0.2 million related to IEEPA tariffs which is included in interest and other income. …”
see in full comparison
Full comparison: every changed paragraph (51)

Green = added, red = removed. Unchanged paragraphs, 4 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Reworded

You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission (“SEC”) on February 26, 2026 (the “Annual Report”). Data as of and for the three and six months ended MarchJune 31,30, 2026 and 2025 has been derived from our unaudited condensed consolidated financial statements. Results for any interim period should not be construed as an inference of what our results would be for any full fiscal year or future period. This discussion and other parts of this Quarterly Report on Form 10-Q contain forward-looking statements, such as those relating to our plans, objectives, expectations, intentions, and beliefs, which involve risks and uncertainties. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the sections titled “Special Note Regarding Forward-Looking Statements” and in Part I, Item 1A, Risk Factors, in the Annual Report.

Reworded

•We’ve built a seamless shopping experience that meets customers where and how they want to shop, whether that’s on our website, on our mobile app, or in our 337352 retail stores as of MarchJune 31,30, 2026.

Reworded

For the three months ended MarchJune 31,30, 2026 and 2025:

Reworded

•we generated net income of $3.2$4.6 million and $3.5net loss of $1.8 million, respectively; and

Added

For the six months ended June 30, 2026 and 2025:

Added

•we generated net revenue of $478.0 million and $438.3 million, respectively;

Added

•we generated gross profit of $267.5 million and $239.6 million, respectively, representing a gross margin of 56.0% and 54.7%, respectively;

Added

•we generated net income of $7.8 million and $1.7 million, respectively; and

Added

•we generated Adjusted EBITDA of $62.4 million and $54.2 million, respectively, representing an Adjusted EBITDA Margin of 13.1% and 12.4%, respectively.

Reworded

For a definitiondefinitions of Adjusted EBITDA and Adjusted EBITDA Margin, a non-GAAP measure,financial measures, and a reconciliationreconciliations to the most directly comparable GAAP measure, see the section titled “Key Business Metrics and Certain Non-GAAP Financial Measures.”

Reworded

In the second quarter of 2025, we announced a partnership with Google to develop AI-enabled glasses intended for all-day wear. We are working closely with Google on the development of AI glasses and intend to launch a series of products over time. As part of this collaborative arrangement, Google has committed up to $75 million for our product development and commercialization costs. In addition, Google has committed to investing up to $75 million in Warby Parker, at our option and subject to reaching certain collaboration milestones. During the three and six months ended MarchJune 31,30, 2026, the Company reduced selling, general, and administrative expenses by $2.0$4.4 million and $6.4 million, respectively, related to costs which are reimbursable by Google and are thus fully offset within the period. To date, wethe haveCompany has incurred $5.3$9.7 million of reimbursable costs.

Reworded

In February 2026, the U.S. Supreme Court issued a ruling striking down certain tariffs previously imposed under the International Emergency Economic Powers Act ("IEEPA"). The U.S. presidential administration subsequently invoked additional tariffs under other laws resulting in a rapidly changing tariff environment. In April 2026, the U.S. Customs and Border Protection agency launched a platform to allow for the submission of IEEPA tariff refund requests. The timingCompany is accounting for any claims as loss recoveries and recognizes receivables when receipt of claimthe acceptanceclaims andbecome paymentprobable. remains uncertain and weRecoveries are inreflected theas processa reduction of estimating the potential financial impactcost of thisgoods ruling.sold Wefor willinventory continuepreviously tosold, monitoror the refund process and will recognizeas a refundreduction whenof theinventory rightfor togoods receivethat anyremain amounts becomes probable.unsold.

Added

During the three and six months ended June 30, 2026, the Company determined that the receipt of refunds totaling $14.4 million of IEEPA tariffs were probable and recorded an $11.8 million benefit to cost of goods sold for inventory sold through June 30, 2026 and a $2.6 million reduction to inventory that will be recorded through cost of goods sold as inventory turns in the second half of 2026. The Company recorded interest income of $0.2 million related to IEEPA tariffs which is included in interest and other income. As of June 30, 2026, $3.4 million of cash had been collected, inclusive of interest, and $11.2 million remained as a receivable within prepaid expenses and other current assets on the Company’s condensed consolidated balance sheet. Subsequent to June 30, 2026, the Company collected all of the remaining tariff receivable.

Reworded

We have expanded our retail store footprint over the past several years. During the three months ended MarchJune 31,30, 2026 and 2025, we opened 1415 and 11 net new retail stores, respectively. As of MarchJune 31,30, 2026, 299315 out of our 337352 retail stores offered in-person eye exams, representing 88.7%89.5% of our fleet, compared to 86.1%86.9% as of MarchJune 31,30, 2025.

Reworded

__________________ (1) Represents expenses related to the Company’s equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions. For the three months ended MarchJune 31,30, 2026 and 2025, the amount includes $0.6$0.4 million and $0.7$0.3 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises. For the six months ended June 30, 2026 and 2025, the amount includes $1.0 million and $0.9 million, respectively, of employer payroll taxes associated with releases of RSUs and option exercises.

Added

(2) Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in both April 2026 and May 2025 to the Warby Parker Impact Foundation.

Added

(4) Represents one-time inventory write-downs primarily related to the decision in the second quarter of 2025 to sunset our Home Try-On program at the end of 2025.

Reworded

(35) Represents restructuring costs incurred in the second quarter of 2025 and charges for certain legal matters outside the ordinary course of business.

Reworded

Selling, general, and administrative expenses, or SG&A, primarily consist of employee-related costs including salaries, benefits, bonuses, and stock-based compensation for our corporate and retail employees, marketing, information technology, credit card processing fees, donations in connection with our Buy a Pair, Give a Pair program, facilities, legal, and other administrative costs associated with operating the business. Marketing, which consistconsists of both online and offline advertising, includes sponsored search, online advertising, Home Try-On program costs, and other initiatives. We expect SG&A to increase in absolute dollars over time and to fluctuate as a percentage of revenue due to the anticipated growth of our business, intentional investments in marketing, and changing prices of goods and services caused by inflation and other macroeconomic factors. SG&A is expensed in the period in which it is incurred.

Reworded

Comparison of the Three Months Ended MarchJune 31,30, 2026 and 2025

Reworded

Net revenue increased $18.7$21.0 million, or 8.3%,9.8%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025. Active Customers increased 4.8%4.1% and Average Revenue per Customer increased to $331$336 from $310$316 in the prior year period. Average Revenue per Customer growth was primarily driven by our eyewear business, which benefited from selectiveincreased price increases implemented during the second quarterpenetration of 2025premium lenses and theenhancements, recognitionlike ofour salesprecision placed in the last few days of 2025 that were delivered in 2026,progressives, as well as an increase in customers purchasing eye exams along with glasses or contacts.

Reworded

Cost of goods sold increaseddecreased by $13.6$1.8 million, or 13.9%,1.8%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, and increaseddecreased as a percentage of revenue over the same period, from 43.7%47.0% of revenue to 46.0%42.1% of revenue. The increasedecrease in cost of goods sold was primarily driven by increased product and fulfillment costs associated with our sales growth, particularly related to opticalthe laboratorybenefit andfrom lensIEEPA costs,tariff andrefunds, partially offset by increases in store occupancy costs and doctor headcount due to new retail stores.

Reworded

Gross profit, calculated as net revenue less cost of goods sold, increased by $5.1$22.8 million, or 4.0%,20.1%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to the increase in net revenue over the same period.period as well as a benefit from IEEPA tariff refunds.

Reworded

Gross margin, expressed as a percentage and calculated as gross profit divided by net revenue, decreasedincreased by 230490 basis points for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025. The decreaseincrease was primarily drivenrelated to a 500 basis point benefit from IEEPA tariff refunds as well as 110 basis points from the one-time inventory write-downs in Q2 2025 related to the sunset of our Home Try-On program. These benefits were partially offset by deleverage in the fixed expenses portion of gross margin, which includes doctor headcount and occupancy, the impact of tariff costs related to glasses, and increased optical laboratory and customer shipping costs. These impacts were partially offset by selective price increases implemented during the second quarter of 2025, and increased penetration of higher margin progressive lenses and other lens enhancements.occupancy.

Reworded

Selling, general, and administrative expenses increased $5.9$15.2 million, or 4.7%,12.8%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025. This increase was primarily driven by higher payroll-related costs from growth in our retail workforce and higher corporate expenses, mainly related to technology costs, partially offset by lower stock-based compensation, mostly related to the 2021 Founders Grant as award tranches became fully expensed.costs. As a percentage of revenue, SG&A decreasedincreased by 180150 basis points, primarily driven by leverageincreased fromretail marketingcompensation and technology costs relatedas toa ourpercent nowof retired Home-Try-On program, stock-based compensation, and corporate expenses,revenue, partially offset by deleveragecustomer fromexperience our retail workforce.efficiencies.

Reworded

Interest and other income, net decreasedincreased $0.1 million, or 5.1%,5.0%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to favorable fluctuations in foreign currency rates, partially offset by lower interest rates on our increased cash and cash equivalents balance.

Reworded

Provision for income taxes decreasedincreased $0.6$1.4 million, or 43.5%,176.9%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to thean impactincrease ofin income before income taxes in the Onecurrent Big Beautiful Bill Act on taxable income.year.

Added

Comparison of the Six Months Ended June 30, 2026 and 2025

Added

Net Revenue

Added

Net revenue increased $39.7 million, or 9.1%, for the six months ended June 30, 2026 compared to the same period in 2025. Active Customers increased 4.1% and Average Revenue per Customer increased to $336 from $316 in the prior year period. Average Revenue per Customer growth was primarily driven by our eyewear business, which benefited from increased penetration of premium lenses and enhancements, like our precision progressives, as well as an increase in customers purchasing eye exams along with glasses or contacts.

Added

Cost of Goods Sold, Gross Profit, and Gross Margin

Added

Cost of goods sold increased by $11.8 million, or 5.9%, for the six months ended June 30, 2026 compared to the same period in 2025, and decreased as a percentage of revenue over the same period, from 45.3% of revenue to 44.0% of revenue. The increase in cost of goods sold was primarily driven by increases in store occupancy costs and doctor headcount due to new retail stores, as well as increased product and fulfillment costs associated with our sales growth, partially offset by the benefit from IEEPA tariff refunds.

Added

Gross profit, calculated as net revenue less cost of goods sold, increased by $27.9 million, or 11.6%, for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to the increase in net revenue over the same period as well as a benefit from IEEPA tariff refunds.

Added

Gross margin, expressed as a percentage and calculated as gross profit divided by net revenue, increased by 130 basis points for the six months ended June 30, 2026 compared to the same period in 2025. The increase was primarily related to a 250 basis point benefit from IEEPA tariff refunds. These benefits were partially offset by deleverage in the fixed portion of gross margin, which includes doctor headcount and occupancy.

Added

Selling, General, and Administrative Expenses

Added

Selling, general, and administrative expenses increased $21.0 million, or 8.7%, for the six months ended June 30, 2026 compared to the same period in 2025. This increase was primarily driven by higher payroll-related costs from growth in our retail workforce and higher corporate expenses, mainly related to technology costs. As a percentage of revenue, SG&A was flat, as customer experience efficiencies, marketing costs related to our now retired Home Try-On program, and stock-based compensation were partially offset by deleverage from our retail workforce.

Added

Interest and Other Income, Net

Added

Interest and other income, net was flat for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to favorable fluctuations in foreign currency rates, offset by lower interest rates on our increased cash and cash equivalents balance.

Added

Provision for Income Taxes

Added

Provision for income taxes increased $0.8 million, or 114.7%, for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to an increase in income before income taxes in the current year.

Reworded

Since inception, we have financed our operations primarily from net proceeds from the sale of redeemable convertible preferred stock and cash flows from operating activities. We also have access to cash from our 2024 Credit Facility, as described below, which remains undrawn as of MarchJune 31,30, 2026. We had cash and cash equivalents of $288.2$292.7 million, which was primarily held for working capital purposes, and an accumulated deficit of $682.4$677.8 million as of MarchJune 31,30, 2026. As of December 31, 2025, we had cash and cash equivalents of $286.4 million, which was primarily held for working capital purposes, and an accumulated deficit of $685.6 million.

Reworded

Under the 2024 Credit Facility, borrowings under the revolving credit facility bear interest on the principal amount outstanding, at the Company’s election, at (a) the greater of the prime rate (as defined in the credit agreement) or 2.5%, plus an applicable margin of 0.65% to 0.90% depending on the Company’s leverage ratio or (b) adjusted SOFR (as defined in the credit agreement), plus an applicable margin of 1.65% to 1.90% depending on the Company’s leverage ratio. The Company is charged an unused commitment fee of 0.20% to 0.25% depending on the Company's leverage ratio. Both interest on principal and commitment fees are includedrecorded inas a reduction to interest expenseand other income, net on the condensed consolidated statements of operations.

Reworded

The 2024 Credit Facility contains a financial maintenance covenant which only applies while total borrowings exceed $30.0 million, which requires the Company to maintain a maximum consolidated senior net leverage ratio of 3:1. The 2024 Credit Facility contains customary affirmative and negative covenants, including limits on indebtedness, liens, capital expenditures, asset sales, investments and restricted payments, in each case subject to negotiated exceptions and baskets, as well as customary representations, warranties and event of default provisions. The obligations of the Borrowers under the 2024 Credit Agreement are secured by first-lien security interests in substantially all of the assets of the Borrowers. In addition, the obligations are required to be guaranteed in the future by certain additional domestic subsidiaries of the Company.

Reworded

Other than letters of credit outstanding of $4.3 million as of both MarchJune 31,30, 2026 and December 31, 2025 used to secure certain leases in lieu of a cash security deposit, there were no other borrowings outstanding under the 2024 Credit Facility.

Reworded

In February 2026, the Company’s Board of Directors authorized a share repurchase program to purchase up to $100.0 million of the Company’s Class A common stock (the “Share Repurchase Program”). Repurchases under the Share Repurchase Program may be made in the open market, in privately negotiated transactions, or otherwise, with the amount and timing of repurchases to be determined at the Company’s discretion, depending on market conditions and corporate needs. Open market repurchases will be structured to occur in accordance with applicable federal securities laws, including within the pricing and volume requirements of Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The Company may also, from time to time, enter into Rule 10b5-1 plans to facilitate repurchases of its shares under this authorization. The Share Repurchase Program does not have a fixed expiration date, does not obligate the Company to acquire any particular amount of Class A common stock, and may be modified, suspended, or terminated at any time at the discretion of the Company’s Board of Directors. During the three and six months ended MarchJune 31,30, 2026, the Company did not purchase any shares under the Share Repurchase Program.

Reworded

Net cash provided by operating activities was $24.5$54.1 million for the threesix months ended MarchJune 31,30, 2026, consisting of net income of $3.2$7.8 million adjusted for $26.6$55.8 million of non-cash expenses and $5.3$9.5 million of net cash used as a result of changes in operating assets and liabilities. The non-cash charges included $13.8$27.8 million of depreciation and amortization, $11.4$21.3 million of stock-based compensation, $1.0$4.0 million of non-cash charitable contributions, $2.1 million of amortization of cloud-based software implementation costs, and $0.5$0.6 million of asset impairment charges. The changes in operating assets and liabilities were primarily driven by a decrease in deferred revenue, partially offset by an increase in prepaid expenses and other assets and inventory.a decrease in deferred revenue, partially offset by increases in accounts payable and accrued expenses.

Reworded

Net cash provided by operating activities was $29.4$69.6 million for the threesix months ended MarchJune 31,30, 2025, consisting of net income of $3.5$1.7 million, adjusted for $25.5$50.7 million of non-cash expenses and $0.4$17.2 million of net cash generated as a result of changes in operating assets and liabilities. The non-cash charges included $12.3 million of stock-based compensation, $12.2$24.6 million of depreciation and amortization, $0.7$21.2 million of stock-based compensation, $2.8 million of non-cash charitable contributions, $1.5 million of amortization of cloud-based software implementation costs, and $0.3$0.5 million of asset impairment charges. The changes in operating assets and liabilities were primarily driven by a decrease in deferredinventory revenue,and an increase in accrued expenses and leasehold liabilities, partially offset by increaseda accountsdecrease payablein anddeferred decreased inventory and prepaid expenses and other assets.revenue.

Reworded

For the threesix months ended MarchJune 31,30, 2026, net cash used in investing activities was $16.1$39.0 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores and investments in capitalized software development costs.

Reworded

For the threesix months ended MarchJune 31,30, 2025, net cash used in investing activities was $16.2$32.4 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores and investments in capitalized software development costs.

Reworded

For the threesix months ended MarchJune 31,30, 2026, net cash used in financing activities was $6.2$8.5 million, which was primarily related to cash paid for shares withheld for taxes for stock-based compensation.compensation, partially offset by proceeds from shares issued in connection with our ESPP and option exercises.

Reworded

For the threesix months ended MarchJune 31,30, 2025, net cash used in financing activities was $2.3$5.1 million, which was primarily related to cash paid for shares withheld for taxes for stock-based compensation.compensation, partially offset by proceeds from shares issued in connection with our ESPP.

WRBY insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 13 filings (6 insiders, 12 trade dates, 900,275 shares, about $25.9M; 11 of these filings say the sales were made under a Rule 10b5-1 trading plan). Net open-market shares: -900,275 (purchases minus sales); net value about -$25.9M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

Trade dateInsiderTransactionSharesPriceValueOwned afterFiling
2026-10-01Raider Jeffrey Jacob
Director
Open-market sale
10b5-1 plan
15,000$27.70 $415.5K420,201 SEC
2026-10-01Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
95,614— —136,020 SEC
2026-10-01Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
100,000$27.69 $2.8M36,020 SEC
2026-09-02Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Option exercise 10,983— —51,910 SEC
2026-09-02Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Option exercise 9,815— —40,927 SEC
2026-09-02Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Shares withheld for tax 11,504$24.19 $278.3K40,406 SEC
2026-09-02Gilboa David Abraham
Director, Co-Chief Executive Officer
Shares withheld for tax 11,504$24.19 $278.3K40,406 SEC
2026-09-02Gilboa David Abraham
Director, Co-Chief Executive Officer
Option exercise 9,815— —40,927 SEC
2026-09-02Gilboa David Abraham
Director, Co-Chief Executive Officer
Option exercise 10,983— —51,910 SEC
2026-07-06Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
9,200$29.99 $275.9K31,112 SEC
2026-07-06Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
9,200— —40,312 SEC
2026-07-06Gilboa David Abraham
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
54,347$29.84 $1.6M31,112 SEC
2026-07-06Gilboa David Abraham
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
54,347— —85,459 SEC
2026-07-01Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
217,667$29.61 $6.4M31,112 SEC
2026-07-01Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
189,320— —248,779 SEC
2026-07-01Gilboa David Abraham
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
242,221$29.69 $7.2M31,112 SEC
2026-07-01Gilboa David Abraham
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
213,746— —273,333 SEC
2026-07-01Raider Jeffrey Jacob
Director
Open-market sale
10b5-1 plan
22,500$29.72 $668.7K435,201 SEC
2026-06-29Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
36,300$30.04 $1.1M59,459 SEC
2026-06-29Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Option exercise
10b5-1 plan
36,300— —95,759 SEC
2026-06-16Briggs Teresa
Director
Open-market sale
10b5-1 plan
3,092$25.41 $78.6K50,791 SEC
2026-06-16Briggs Teresa
Director
Open-market sale
10b5-1 plan
1,908$26.79 $51.1K48,883 SEC
2026-06-12Moon Youngme E
Director
Open-market sale 10,000$26.53 $265.3K26,061 SEC
2026-06-08Williams Ronald A
Director
Grant/award 13,006— —113,629 SEC
2026-06-08Singer Bradley E
Director
Grant/award 9,004— —25,030 SEC
2026-06-08Raider Jeffrey Jacob
Director
Grant/award 9,004— —457,701 SEC
2026-06-08Hunt Andrew
Director
Grant/award 12,005— —1,941,236 SEC
2026-06-08Moon Youngme E
Director
Grant/award 9,004— —36,061 SEC
2026-06-08Briggs Teresa
Director
Grant/award 9,004— —53,883 SEC
2026-06-02Gilboa David Abraham
Director, Co-Chief Executive Officer
Option exercise 10,983— —71,092 SEC
2026-06-02Gilboa David Abraham
Director, Co-Chief Executive Officer
Shares withheld for tax 11,505$24.38 $280.5K59,587 SEC
2026-06-02Gilboa David Abraham
Director, Co-Chief Executive Officer
Option exercise 9,816— —60,109 SEC
2026-06-02Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Option exercise 9,816— —59,981 SEC
2026-06-02Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Option exercise 10,983— —70,964 SEC
2026-06-02Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Shares withheld for tax 11,505$24.38 $280.5K59,459 SEC
2026-05-19Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
63,040$30.03 $1.9M50,165 SEC
2026-05-19Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
63,040— —113,205 SEC
2026-05-14Singer Bradley E
Director
Open-market sale 4,833$29.01 $140.2K100,000 SEC
2026-05-13Singer Bradley E
Director
Open-market sale 20,167$28.51 $575.0K104,833 SEC
2026-04-20Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
22,442— —72,607 SEC
2026-04-20Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
22,442$25.09 $563.1K50,165 SEC
2026-04-17Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
27,558$25.04 $690.1K50,165 SEC
2026-04-17Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
27,558— —77,723 SEC
2026-04-17Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
47,655$24.29 $1.2M50,165 SEC
2026-04-17Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
47,655— —97,820 SEC
2026-04-16Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Conversion
10b5-1 plan
2,345— —52,510 SEC
2026-04-16Blumenthal Neil Harris
Director, Co-Chief Executive Officer
Open-market sale
10b5-1 plan
2,345$24.08 $56.5K50,165 SEC

Well-known investors holding WRBY (13F)

InvestorQuarterSharesReported value% of their 13FChange vs prior quarter
Durable Capital Partners (Henry Ellenbogen) CL A COM2026-06-306,396,513$194.1M1.89%No change
Millennium Management (Israel Englander) CL A COM2026-06-30828,815$25.1M0.02%Added 57%
AQR Capital Management (Cliff Asness) CL A COM2026-06-30765,069$23.2M0.01%Reduced 19%
Point72 Asset Management (Steve Cohen) CL A COM2026-06-30336,069$10.2M0.02%Added 648%
Citadel Advisors (Ken Griffin) CL A COM2026-06-30334,234$10.1M0.01%Reduced 41%
First Eagle Investment Management CL A COM2026-06-30288,000$8.7M0.01%Added 113%
Renaissance Technologies CL A COM2026-06-30209,336$6.4M0.01%Reduced 62%
Bridgewater Associates CL A COM2026-06-30171,520$3.6M—Sold out
Baillie Gifford CL A COM2026-06-30169,148$3.6M—Sold out
Gardner Russo & Quinn (Tom Russo) COM2026-06-3080,000$2.4M0.03%No change
Two Sigma Investments CL A COM2026-06-3055,335$1.7M0.0%Reduced 75%
D. E. Shaw & Co. CL A COM2026-06-3041,320$870.6K—Sold out

13F reports are filed up to 45 days after quarter end and show long U.S. equity positions only; options positions are omitted here.

Coming soon: email alerts when WRBY files, watchlists and downloadable comparisons.